Epigenetik Mekanizmaların Akciğer Kanseri Biyolojisindeki Rolü: Bibliyometrik Perspektif

Aria, M., & Cuccurullo, C. (2017). bibliometrix: An R-tool for comprehensive science mapping analysis. Journal of Informetrics, 11(4), 959–975. https://doi.org/10.1016/J.JOI.2017.08.007

Bartoszewska, E., Misiąg, P., Czapla, M., Rakoczy, K., Tomecka, P., Filipski, M., … Choromańska, A. (2025). The Role of microRNAs in Lung Cancer: Mechanisms, Diagnostics and Therapeutic Potential. International journal of molecular sciences, 26(8). https://doi.org/10.3390/IJMS26083736

Cho, J. H., Oezkan, F., Koenig, M., Otterson, G. A., Herman, J. G., & He, K. (2017). Epigenetic Therapeutics and Their Impact in Immunotherapy of Lung Cancer. Current pharmacology reports, 3(6), 360–373. https://doi.org/10.1007/S40495-017-0110-5

Daskalos, A., Nikolaidis, G., Xinarianos, G., Savvari, P., Cassidy, A., Zakopoulou, R., … Liloglou, T. (2009). Hypomethylation of retrotransposable elements correlates with genomic instability in non-small cell lung cancer. International Journal of Cancer, 124(1), 81–87. https://doi.org/10.1002/IJC.23849

Fabbri, M., Garzon, R., Cimmino, A., Liu, Z., Zanesi, N., Callegari, E., … Croce, C. M. (2007). MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proceedings of the National Academy of Sciences, 104(40), 15805–15810. https://doi.org/10.1073/PNAS.0707628104

Gazdar, A. F., Bunn, P. A., & Minna, J. D. (2017). Small-cell lung cancer: What we know, what we need to know and the path forward. Nature Reviews Cancer, 17(12), 725–737. https://doi.org/10.1038/NRC.2017.87;SUBJMETA

Hu, D., Zhao, T., Xu, C., Pan, X., Zhou, Z., & Wang, S. (2024). Epigenetic Modifiers in Cancer Metastasis. Biomolecules 2024, Vol. 14, Page 916, 14(8), 916. https://doi.org/10.3390/BIOM14080916

Karagur, E. R., Ozay, C., Mammadov, R., & Akca, H. (2018a). Anti-invasive effect of Cyclamen pseudibericum extract on A549 non-small cell lung carcinoma cells via inhibition of ZEB1 mediated by miR-200c. Journal of Natural Medicines. https://doi.org/10.1007/s11418-018-1204-z

Le, M. T., Nguyen, H. T., Nguyen, X. H., Do, X. H., Mai, B. T., Ngoc Nguyen, H. T., … Nguyen, T. H. (2023). Regulation and therapeutic potentials of microRNAs to non-small cell lung cancer. Heliyon, 9(11). https://doi.org/10.1016/j.heliyon.2023.e22080

Levine, M. E., Hosgood, H. D., Chen, B., Absher, D., Assimes, T., & Horvath, S. (2015). DNA methylation age of blood predicts future onset of lung cancer in the women’s health initiative. Aging, 7(9), 690–700. https://doi.org/10.18632/AGING.100809

Li, R., Zhou, R., & Zhang, J. (2018). Function of PM2.5 in the pathogenesis of lung cancer and chronic airway inflammatory diseases. Oncology Letters, 15(5), 7506–7514. https://doi.org/10.3892/OL.2018.8355/HTML

Lu, F., & Zhang, H. T. (2011). DNA methylation and nonsmall cell lung cancer. Anatomical record (Hoboken, N.J. : 2007), 294(11), 1787–1795. https://doi.org/10.1002/AR.21471

Matsumoto, S., Iwakawa, R., Takahashi, K., Kohno, T., Nakanishi, Y., Matsuno, Y., … Yokota, J. (2007). Prevalence and specificity of LKB1 genetic alterations in lung cancers. Oncogene, 26(40), 5911–5918. https://doi.org/10.1038/SJ.ONC.1210418;KWRD

Rosenthal, R., Cadieux, E. L., Salgado, R., Al-Bakir, M., Moore, D. A., Hiley, C. T., … Kidd, A. (2019). Neoantigen-directed immune escape in lung cancer evolution. Nature, 567(7749), 479–485. https://doi.org/10.1038/S41586-019-1032-7;TECHMETA

Sekido, Y., Fong, K. M., & Minna, J. D. (2003). Molecular Genetics of Lung Cancer. Annual Review of Medicine, 54(Volume 54, 2003), 73–87. https://doi.org/10.1146/ANNUREV.MED.54.101601.152202/CITE/REFWORKS

Sharma, S., Kelly, T. K., & Jones, P. A. (2009). Epigenetics in cancer. Carcinogenesis, 31(1), 27. https://doi.org/10.1093/CARCIN/BGP220

Tan, A. C. (2020). Targeting the PI3K/Akt/mTOR pathway in non-small cell lung cancer (NSCLC). Thoracic Cancer, 11(3), 511–518. https://doi.org/10.1111/1759-7714.13328

Testa, U., Castelli, G., & Pelosi, E. (2018). Lung Cancers: Molecular Characterization, Clonal Heterogeneity and Evolution, and Cancer Stem Cells. Cancers 2018, Vol. 10, Page 248, 10(8), 248. https://doi.org/10.3390/CANCERS10080248

Yang, D., Liu, Y., Bai, C., Wang, X., & Powell, C. A. (2020). Epidemiology of lung cancer and lung cancer screening programs in China and the United States. Cancer Letters, 468, 82–87. https://doi.org/10.1016/J.CANLET.2019.10.009

Yang, H., Liu, Y., Chen, L., Zhao, J., Guo, M., Zhao, X., … Xu, L. (2023). MiRNA-Based Therapies for Lung Cancer: Opportunities and Challenges? Biomolecules, 13(6). https://doi.org/10.3390/BIOM13060877